These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33586037)

  • 21. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The β
    Braadland PR; Ramberg H; Grytli HH; Urbanucci A; Nielsen HK; Guldvik IJ; Engedal A; Ketola K; Wang W; Svindland A; Mills IG; Bjartell A; Taskén KA
    Mol Cancer Res; 2019 Nov; 17(11):2154-2168. PubMed ID: 31395667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroendocrine tumors of the prostate.
    Fine SW
    Mod Pathol; 2018 Jan; 31(S1):S122-132. PubMed ID: 29297494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does neuroendocrine differentiation have prognostic value in prostate core needle biopsies?].
    Jaskulski J; Gołabek T; Kopczyński J; Orłowsk P; Bukowczan J; Dudek P; Chłosta P
    Przegl Lek; 2013; 70(11):933-5. PubMed ID: 24697032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcomatoid carcinoma of the prostate: a study of 42 cases.
    Hansel DE; Epstein JI
    Am J Surg Pathol; 2006 Oct; 30(10):1316-21. PubMed ID: 17001164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases.
    Bell PD; Huber AR; Agostini-Vulaj D
    Diagn Pathol; 2021 Apr; 16(1):35. PubMed ID: 33892760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine transdifferentiation of prostate carcinoma cells and its prognostic significance.
    Marcu M; Radu E; Sajin M
    Rom J Morphol Embryol; 2010; 51(1):7-12. PubMed ID: 20191113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer with neuroendocrine differentiation--case report.
    Glück G; Mihai M; Stoica R; Andrei R; Sinescu I
    J Med Life; 2012 Feb; 5(1):101-4. PubMed ID: 22574096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.
    Becker F; Joerg V; Hupe MC; Roth D; Krupar R; Lubczyk V; Kuefer R; Sailer V; Duensing S; Kirfel J; Merseburger AS; Brägelmann J; Perner S; Offermann A
    Int J Cancer; 2020 Jan; 146(2):577-588. PubMed ID: 31271443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine cells of prostate cancer: biologic functions and molecular mechanisms.
    Huang YH; Zhang YQ; Huang JT
    Asian J Androl; 2019; 21(3):291-295. PubMed ID: 30924452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic, Molecular and Clinical Features of Aggressive Variant Prostate Cancer.
    Montironi R; Cimadamore A; Lopez-Beltran A; Scarpelli M; Aurilio G; Santoni M; Massari F; Cheng L
    Cells; 2020 Apr; 9(5):. PubMed ID: 32344931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-needle aspiration of metastatic prostatic neuroendocrine carcinomas: cytomorphologic and immunophenotypic features.
    Cai G; Ramdall RB; Levine P; Yang GC
    Diagn Cytopathol; 2008 Aug; 36(8):545-9. PubMed ID: 18618716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells.
    Pernicová Z; Slabáková E; Fedr R; Šimečková Š; Jaroš J; Suchánková T; Bouchal J; Kharaishvili G; Král M; Kozubík A; Souček K
    Mol Cancer; 2014 May; 13():113. PubMed ID: 24884804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer.
    Zhang X; Coleman IM; Brown LG; True LD; Kollath L; Lucas JM; Lam HM; Dumpit R; Corey E; Chéry L; Lakely B; Higano CS; Montgomery B; Roudier M; Lange PH; Nelson PS; Vessella RL; Morrissey C
    Clin Cancer Res; 2015 Oct; 21(20):4698-708. PubMed ID: 26071481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer.
    Dong B; Miao J; Wang Y; Luo W; Ji Z; Lai H; Zhang M; Cheng X; Wang J; Fang Y; Zhu HH; Chua CW; Fan L; Zhu Y; Pan J; Wang J; Xue W; Gao WQ
    Commun Biol; 2020 Dec; 3(1):778. PubMed ID: 33328604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
    Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
    Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Correlation between PSCA Expression and Neuroendocrine Differentiation in Prostate Cancer.
    Xiang Q; Zhu Z; Luo L; Wang J; Liu Y; Deng Y; Zhou M; Zhao Z
    Biomed Res Int; 2020; 2020():5395312. PubMed ID: 33029516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma.
    Ostano P; Mello-Grand M; Sesia D; Gregnanin I; Peraldo-Neia C; Guana F; Jachetti E; Farsetti A; Chiorino G
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine-like prostate cancer cells: neuroendocrine transdifferentiation of prostate adenocarcinoma cells.
    Yuan TC; Veeramani S; Lin MF
    Endocr Relat Cancer; 2007 Sep; 14(3):531-47. PubMed ID: 17914087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.